AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hohl, C.
Right arrow Articles by Wildberger, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hohl, C.
Right arrow Articles by Wildberger, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2005; 184:128-130
© American Roentgen Ray Society

Radiation Dose Reduction to the Male Gonads During MDCT: The Effectiveness of a Lead Shield

Christian Hohl1, Andreas H. Mahnken1, Ernst Klotz2, Marco Das1, Achim Stargardt1,3, Georg Mühlenbruch1, Thorsten Schmidt1, Rolf W. Günther1 and Joachim E. Wildberger1

1 Department of Diagnositc Radiology, University of Technology of Aachen, Paulwelsstrasse 30, Aachen D-52057, Germany.
2 Siemens Medical Solutions, Computed Tomography, Siemensstrasse 1, Forchheim D-91301, Germany.
3 Deceased.

OBJECTIVE. Our study was designed to quantify the effect of a standard gonad shield on the testicular radiation exposure due to scatter during routine abdominopelvic MDCT.

SUBJECTS AND METHODS. Routine abdominopelvic MDCT was performed in 34 patients with gonadal lead shielding and 32 patients without this shielding; the testes were not exposed to the direct beam during the examination. We estimated the testicular dose administered with thermoluminescent dosimetry, taking into account each patient's body weight and body mass index (BMI).

RESULTS. With a 1-mm lead shield, the mean testicular dose was reduced from 2.40 to 0.32 mSv, a reduction of 87%. The difference was found to be statistically significant (p < 0.0001). No correlation between testicular dose and body weight or BMI was found.

CONCLUSION. Shielding the male gonads reduces the testicular radiation dose during abdominopelvic MDCT significantly and can be recommended for routine use.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
S L FAWCETT and S J BARTER
The use of gonad shielding in paediatric hip and pelvis radiographs
Br. J. Radiol., May 1, 2009; 82(977): 363 - 370.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
D. Honnef, J. E. Wildberger, G. Haras, C. Hohl, G. Staatz, R. W. Gunther, and A. H. Mahnken
Prospective Evaluation of Image Quality with Use of a Patient Image Gallery for Dose Reduction in Pediatric 16-MDCT
Am. J. Roentgenol., February 1, 2008; 190(2): 467 - 473.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
E V Kennedy, G R Iball, and D S Brettle
Investigation into the effects of lead shielding for fetal dose reduction in CT pulmonary angiography
Br. J. Radiol., August 1, 2007; 80(956): 631 - 638.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Roentgen Ray Society.